Medical Testing

Researchers looking into possible benefits of people receiving two different coronavirus vaccines

Fri, 2021-06-25 09:41 — mike kraft

The most widely used coronavirus vaccines are designed as two-shot inoculations, and nearly everyone worldwide who has had both doses has received the same vaccine both times.

But that is changing, as more countries are allowing — and even, in some cases, encouraging — mix-and-match inoculation, with people receiving a first shot of one vaccine, and then a second shot of a different one. On Tuesday, Germany’s government revealed that Chancellor Angela Merkel had received two different shots, adding to the growing interest in the practice.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Researchers looking into possible benefits of people receiving two different coronavirus vaccines
Log in or register to post comments

COVID-19 Booster Issue" WHO estimates boosters may be needed yearly for the most vulnerable

Thu, 2021-06-24 15:41 — mike kraft

EXCLUSIVE WHO estimates COVID-19 boosters needed yearly for most vulnerable The World Health Organization (WHO) forecasts that people most vulnerable to COVID-19, such as the elderly, will need to get an annual vaccine booster to be protected against variants, an internal document seen by Reuters shows. Francesco Guarascio Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about COVID-19 Booster Issue" WHO estimates boosters may be needed yearly for the most vulnerable
Log in or register to post comments

EU drug regulator encouraged by early data on mixing coronavirus vaccines

Thu, 2021-06-24 10:55 — mike kraft

EU drug regulator positive on early data on mixing coronavirus vaccines Due to how the approved vaccines all stimulate an immune response through the spike protein, the EMA believes there is good reason to believe that mixing vaccines is both safe and effective. POLITICO

The European Medicines Agency Wednesday said there are “good scientific grounds” to suggest that mixing COVID-19 vaccines is safe and effective.

That’s because, currently, all the approved vaccines work in a similar way — by stimulating an immune response to the viral spike protein, the EMA said in an email.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about EU drug regulator encouraged by early data on mixing coronavirus vaccines
Log in or register to post comments

WHO cites concerns about Russian Sputnik V vaccine plant; company says issues resolved

Wed, 2021-06-23 18:42 — mike kraft

WHO cites concerns about Russian Sputnik V plant, which says issues resolved The World Health Organization said its review of how Russia produces the Sputnik V coronavirus vaccine had found some issues with the filling of vials at one plant, which said it had since addressed all of the WHO's concerns. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about WHO cites concerns about Russian Sputnik V vaccine plant; company says issues resolved
Log in or register to post comments

U.S.Health officials, professional groups say COVID-19 vaccines safe for adolescents; heart incidents extremely rare and mild.

Wed, 2021-06-23 17:59 — mike kraft

Top federal health officials, professional groups say COVID-19 vaccines safe for adolescents Top administration health officials joined with a host of groups representing physicians, hospitals, nurses and others to endorse the safety of COVID-19 vaccines for adolescents. Nathaniel Weixel TheHill

Top administration health officials joined with a host of groups representing physicians, hospitals, nurses and others to endorse the safety of COVID-19 vaccines for adolescents.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Explainer: the Delta variant of coronavirus with K417N mutation

Wed, 2021-06-23 09:41 — mike kraft

Explainer: What is the Delta variant of coronavirus with K417N mutation? India said on Wednesday it has found around 40 cases of the Delta coronavirus variant carrying a mutation that appears to make it more transmissible, and advised states to increase testing. WHAT IS DELTA PLUS?

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Explainer: the Delta variant of coronavirus with K417N mutation
Log in or register to post comments

AstraZeneca, Pfizer vaccines both effective against Delta COVID-19 variants-study

Wed, 2021-06-23 09:32 — mike kraft

AstraZeneca, Pfizer vaccines effective against Delta COVID-19 variants-study COVID-19 vaccines made by AstraZeneca (AZN.L) and the Pfizer-BioNTech (PFE.N), (22UAy.DE) alliance remain broadly effective against Delta and Kappa variants of the COVID-19 causing virus, which were first identified in India, according to a scientific study, underpinning a continued push to deliver the shots. Ludwig Burger,Aishwarya Nair

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about AstraZeneca, Pfizer vaccines both effective against Delta COVID-19 variants-study
Log in or register to post comments

AstraZeneca says its vaccine is effective against COVID-19 variants identified in India

Tue, 2021-06-22 19:05 — mike kraft

AstraZeneca vaccine effective against COVID-19 variants identified in India AstraZeneca Plc's (AZN.L) COVID-19 vaccine is effective against Delta and Kappa variants, which were first identified in India, the company said on Tuesday, citing a study. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about AstraZeneca says its vaccine is effective against COVID-19 variants identified in India
Log in or register to post comments

Cuba says its Abdala vaccine is 92.28% effective against coronavirus

Tue, 2021-06-22 10:29 — mike kraft

Cuba says Abdala vaccine 92.28% effective against coronavirus

HAVANA, June 21 (Reuters) - Cuba said on Monday its three-shot Abdala vaccine against the coronavirus had proved 92.28% effective in last-stage clinical trials.

The announcement came just days after the government said another homegrown vaccine, Soberana 2, had proved 62% effective with just two of its three doses. ...

The announcement came from state-run biopharmaceutical corporation BioCubaFarma, which oversees Finlay, the maker of Soberana 2, and the Center for Genetic Engineering and Biotechnology, the producer of Abdala.

Country / Region Tags:

General Topic Tags: